Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. GenMark Diagnostics
GNMK

Buy GenMark Diagnostics (GNMK) Stock

GNMK
See GNMK stock price and Buy/Sell GenMark Diagnostics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
GNMK

GenMark Diagnostics (GNMK)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About GenMark Diagnostics (GNMK)

GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its sensor detection technology. The Company’s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA) and is designed to support a range of molecular dia...Read more
Market Cap
$1.77B
1 Year High
$24.25
Volume
1 Year Low
$8.47
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch GNMK stock

GenMark Diagnostics Stock News

GenMark Diagnostics stock rating

What analysts recommend for GNMK stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.1

GenMark Diagnostics price target

What analysts think GNMK will be worth
Low $0
High $24.25
Current $0
Target $10.14

Events

List of events that could affect GNMK stock.
25Feb

Earnings data Q4 2020

04May

Earnings data Q1 2021

GenMark Diagnostics earnings

The value each share was expected to gain vs. the value that each share actually gained
0.07
0.03
-0.01
-0.05
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
$0.04
Actual EPS
Q3 2022

Buy GenMark Diagnostics (GNMK) Stock

GNMK
See GNMK stock price and Buy/Sell GenMark Diagnostics with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch GNMK stock
  • steelbeer avatar
  • Prizzi521 avatar
  • Speedie avatar
  • fazlulhoque avatar
  • jodiekesh avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.